ConductScience.org, home

Paper1998970

Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.

Wawrzynczak EJ and 6 others. Cancer Immunol Immunother, 1991. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin. Papers, record 1998970. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1998970

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1991
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
0.8
iCite
Revised in PubMed
2024-04-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wawrzynczak EJE J
2Watson GJG J
3Cumber AJA J
4Henry RVR V
5Parnell GDG D
6Rieber EPE P
7Thorpe PEP E

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD4 AntigensMajor topic
ImmunotoxinsMajor topic
RicinMajor topic
Animals
Antibodies, Monoclonal
B-Lymphocytes
Binding Sites
Binding, Competitive
Cell Survival
Cells, Cultured
Galactose
Goats
Humans
Lactose
Mice
Neoplasms
Peptides
T-Lymphocytes
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13495593Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia.J Immunol1987https://conductscience.org/library/papers/3495593PubMed
22957434Inhibition of the helper function of murine T cells with Fab'-anti-L3T4 ricin A chain immunotoxin.J Immunol1987https://conductscience.org/library/papers/2957434PubMed
33495199Purification of immunotoxins containing ricin A-chain and abrin A-chain using blue sepharose CL-6B.Anal Biochem1987https://conductscience.org/library/papers/3495199PubMed
43261884Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity.Scand J Immunol1988https://conductscience.org/library/papers/3261884PubMed
53064097Antibody toxin conjugates: a perspective.Prog Allergy1988https://conductscience.org/library/papers/3064097PubMed
63317828Redesigning nature's poisons to create anti-tumor reagents.Science1987https://conductscience.org/library/papers/3317828PubMed
73957927Purification of ricin A1, A2, and B chains and characterization of their toxicity.J Biol Chem1986https://conductscience.org/library/papers/3957927PubMed
82430333Epitopes of the CD4 antigen and HIV infection.Science1986https://conductscience.org/library/papers/2430333PubMed
93876881Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.Cancer Res1985https://conductscience.org/library/papers/3876881PubMed
104338881The interaction of Ricinus communis agglutinin with normal and tumor cell surfaces.Biochim Biophys Acta1972https://conductscience.org/library/papers/4338881PubMed
116120167Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution.J Biol Chem1982https://conductscience.org/library/papers/6120167PubMed
127471212Studies on the galactose-binding site of ricin and the hybrid toxin Man6P-ricin.Cell1981https://conductscience.org/library/papers/7471212PubMed
136544125Delivery of ricin and abrin A-chains to human carcinoma cells in culture following covalent linkage to monoclonal antibody LICR-LOND-Fib 75.Cancer Drug Deliv1984https://conductscience.org/library/papers/6544125PubMed
147042536The preparation and cytotoxic properties of antibody-toxin conjugates.Immunol Rev1982https://conductscience.org/library/papers/7042536PubMed
156578512Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6578512PubMed
162445469Studies on the mechanism of action of abrin-9.2.27 immunotoxin in human melanoma cell lines.Cancer Res1987https://conductscience.org/library/papers/2445469PubMed
176736871Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain.J Exp Med1984https://conductscience.org/library/papers/6736871PubMed
183900635Preparation of antibody-toxin conjugates.Methods Enzymol1985https://conductscience.org/library/papers/3900635PubMed
192841982Ricin B chain-containing immunotoxins prepared with heat-denatured B chain lacking galactose-binding ability potentiate the cytotoxicity of a cell-reactive ricin A chain immunotoxin.Biochim Biophys Acta1988https://conductscience.org/library/papers/2841982PubMed
206653781Ricin B chain converts a non-cytotoxic antibody-ricin A chain conjugate into a potent and specific cytotoxic agent.FEBS Lett1983https://conductscience.org/library/papers/6653781PubMed

See all 23 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
31359089Ricin and Ricinus communis in pharmacology and toxicology-from ancient use and "Papyrus Ebers" to modern perspectives and "poisonous plant of the year 2018".Naunyn Schmiedebergs Arch Pharmacol2019https://conductscience.org/library/papers/31359089PubMed
29076988The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations.Toxins (Basel)2017https://conductscience.org/library/papers/29076988PubMed
26349746Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances.Tumour Biol2015https://conductscience.org/library/papers/26349746PubMed
25341935Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.Curr Pharm Des2014https://conductscience.org/library/papers/25341935PubMed
22191802Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate.Cancer Biother Radiopharm2012https://conductscience.org/library/papers/22191802PubMed
10569193Comparative studies on kinetics of inhibition of protein synthesis in intact cells by ricin and a conjugate of ricin B-chain with momordin.Mol Cell Biochem1999https://conductscience.org/library/papers/10569193PubMed
9685864Effect of gelonin immunoconjugate with monoclonal antibody MSN-1 to endometrial adenocarcinoma on antigen-producing tumor cells in vivo.Jpn J Cancer Res1998https://conductscience.org/library/papers/9685864PubMed
1911210Systemic immunotoxin therapy of cancer: advances and prospects.Br J Cancer1991https://conductscience.org/library/papers/1911210PubMed
1394342Antitumour activity of a sterically blocked ricin immunotoxin on a human colorectal adenocarcinoma grafted subcutaneously in nude mice.Cancer Immunol Immunother1992https://conductscience.org/library/papers/1394342PubMed
1394340Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function.Cancer Immunol Immunother1992https://conductscience.org/library/papers/1394340PubMed
1287032Targeted kill: from umbrellas to monoclonal antibodies.J Clin Immunol1992https://conductscience.org/library/papers/1287032PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1998970

GET https://conductscience.org/api/papers/v1/1998970/references?page=2